Clin2
NCT06911632Possibly a fitRecruiting

AI-assisted check for pulmonary hypertension in interstitial lung disease

Pulmonary HypertensionInterstitial Lung Disease (ILD)

Part of Heart & circulation, Lungs & breathing clinical trials.

This study uses an AI tool to help doctors decide if you should be tested for pulmonary hypertension (high blood pressure in the lungs), which can be a complication of interstitial lung disease. If the tool suggests you might have it, you may get an echocardiogram (an ultrasound of the heart) and a right heart catheterization (a test to measure pressure in the heart) to find out for sure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
900 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with interstitial lung disease (a group of lung conditions causing scarring).
  • Your lung function test (DLCO) is less than 30% of the expected value, measured within the last 6 months.
  • You are willing to have an echocardiogram and right heart catheterization if needed.
  • You do not already have a diagnosis of pulmonary hypertension and have not taken specific medicines for it.
  • You have not had a right heart catheterization in the past year, and you do not have any condition (like pregnancy or a mechanical heart valve) that makes this test unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05566002Recruiting
AI review of test results for pulmonary hypertension

This trial uses an artificial intelligence tool to look at results from tests used to evaluate pulmonary hypertension. It may help doctors make sense of your past test results, especially heart and lung evaluation results.

Beijing, Beijing Municipality
NCT07236970Recruiting
AI screening for pulmonary hypertension in scleroderma

This study uses artificial intelligence to find better ways to screen for pulmonary arterial hypertension (a type of high blood pressure in the lungs) in people with systemic sclerosis (scleroderma). The goal is to catch the condition earlier so treatment can start sooner.

Granada, Andalusia
NCT07147725Not yet recruiting
Using artificial intelligence to detect high blood pressure in the lungs

This study uses artificial intelligence to look for signs of pulmonary arterial hypertension (high blood pressure in the lungs) and related heart problems using heart ultrasound images and stethoscope recordings. Participating could help improve detection of this condition.

London
NCT07079592Recruiting
Detecting pulmonary hypertension with AI and EKGs

This trial uses an artificial intelligence program to analyze a standard EKG to see if it can detect pulmonary hypertension (high blood pressure in the lungs). It might help find the condition earlier and without invasive tests.

Taipei
NCT05942859Enrolling by invitation
AI study using heart ECGs to spot pulmonary hypertension

This study looks at patterns on a 12-lead ECG (a common heart tracing) to help diagnose pulmonary hypertension, using results from a right heart catheter test. It may help doctors use ECGs better in the future, without changing your current care.

Bath
NCT07344207Not yet recruiting
Using AI to detect heart risks before surgery

This study tests whether an artificial intelligence program that analyzes your heart's electrical activity (ECG) can help detect if you are at risk for a serious lung condition (pulmonary hypertension) before surgery. If this works, doctors might be able to keep you safer during and after surgery.

Taipei

Hear when a new Pulmonary Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.